News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Year: 2024

Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30.04.2024 / 15:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 Berlin (Germany), April 30, 2024 – Jens Ravens, Executive […]

Read more

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Gesamtstimmrechte | 10 April 2024 11:33 Epigenomics AG / Total Voting Rights Announcement Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 10.04.2024 / 11:33 CET/CEST Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG. The issuer […]

Read more

Epigenomics AG publishes financial results for fiscal year 2023

EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual ReportEpigenomics AG publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2023 Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial […]

Read more

Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Gesamtstimmrechte | 12 März 2024 08:51 Epigenomics AG / Total Voting Rights Announcement Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 12.03.2024 / 08:51 CET/CEST Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG. The issuer […]

Read more

Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

Vorabbekanntmachung | 6 März 2024 09:22 Epigenomics AG / Preliminary announcement on the disclosure of financial statements Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] 06.03.2024 / 09:22 CET/CEST Preliminary announcement of the publication of financial reports according to Articles […]

Read more

Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet

EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet 15.02.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet Berlin, February 15, 2024 – Epigenomics AG (Frankfurt General […]

Read more